Mountain Pacific Investment Advisers LLC Has $13.51 Million Stake in Teleflex Incorporated (NYSE:TFX)

Mountain Pacific Investment Advisers LLC reduced its position in shares of Teleflex Incorporated (NYSE:TFX) by 1.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 75,892 shares of the medical technology company’s stock after selling 993 shares during the period. Mountain Pacific Investment Advisers LLC’s holdings in Teleflex were worth $13,507,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the company. Point72 Asset Management L.P. grew its stake in shares of Teleflex by 564.3% during the 2nd quarter. Point72 Asset Management L.P. now owns 310,484 shares of the medical technology company’s stock worth $65,304,000 after acquiring an additional 263,743 shares in the last quarter. Janus Henderson Group PLC increased its stake in Teleflex by 2.8% in the 3rd quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company’s stock valued at $1,329,704,000 after buying an additional 147,147 shares during the last quarter. FMR LLC lifted its position in Teleflex by 70.1% during the 3rd quarter. FMR LLC now owns 269,490 shares of the medical technology company’s stock worth $66,650,000 after buying an additional 111,086 shares in the last quarter. Kimelman & Baird LLC acquired a new position in shares of Teleflex during the 2nd quarter worth about $21,232,000. Finally, Assenagon Asset Management S.A. increased its position in shares of Teleflex by 457.6% in the third quarter. Assenagon Asset Management S.A. now owns 120,311 shares of the medical technology company’s stock valued at $29,755,000 after acquiring an additional 98,735 shares during the last quarter. 95.62% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research analysts recently commented on TFX shares. Truist Financial reduced their price target on Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a research report on Wednesday, December 18th. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a report on Monday, December 16th. Royal Bank of Canada dropped their price target on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a research report on Friday, November 1st. StockNews.com upgraded shares of Teleflex from a “hold” rating to a “buy” rating in a research note on Thursday, November 28th. Finally, Mizuho cut their target price on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research note on Friday, November 1st. Three research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $252.50.

Teleflex Price Performance

NYSE:TFX opened at $181.56 on Tuesday. Teleflex Incorporated has a 52 week low of $171.69 and a 52 week high of $256.85. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The firm’s 50-day simple moving average is $184.14 and its 200 day simple moving average is $215.49. The firm has a market cap of $8.43 billion, a price-to-earnings ratio of 36.10, a P/E/G ratio of 1.71 and a beta of 1.16.

Teleflex (NYSE:TFX) last released its quarterly earnings results on Thursday, October 31st. The medical technology company reported $3.49 earnings per share for the quarter, beating analysts’ consensus estimates of $3.38 by $0.11. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The company had revenue of $764.40 million during the quarter, compared to the consensus estimate of $768.68 million. During the same period in the previous year, the business earned $3.64 earnings per share. The firm’s quarterly revenue was up 2.4% on a year-over-year basis. As a group, sell-side analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, December 16th. Investors of record on Friday, November 15th were given a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.75%. The ex-dividend date was Friday, November 15th. Teleflex’s payout ratio is currently 27.04%.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.